Sanofi Sales, Profit Beat Forecasts
Wall Street Journal
Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.
https://www.wsj.com/articles/sanofi-sales-profit-beat-expectations-1c9ff477